Ro Alternatives: Best Options for GLP-1, ED, Hair Loss, and Mental Health

Is Ro Legit? A Critical Assessment

Ro is a licensed telehealth company founded in 2017. It operates its own pharmacy network (Ro Pharmacy) and employs board-certified prescribers. The company is not a scam, and its prescribers must follow state-specific prescribing laws. "legitimate" does not automatically mean "best value" or "most effective" for your specific situation.

What Ro Does Well

Ro's vertically integrated model means your prescription, lab order, and shipment are coordinated inside one platform. For patients who value convenience over price, that has real appeal. Ro also publishes its ingredient sourcing for compounded GLP-1 peptides, which puts it ahead of many gray-market peptide vendors.

Where Ro Falls Short

Ro's compounded semaglutide pricing has historically run $299 per month or higher, depending on dose. Several competitors offer the same compounded formulation for $150 to $199 per month. Ro's mental health program is asynchronous for initial consults, which may not meet the standard of care for patients with moderate-to-severe depression. A 2023 JAMA Internal Medicine analysis of direct-to-consumer telehealth platforms found that async-only mental health prescribing raised concerns about diagnostic thoroughness [1].

Regulatory Context

The FDA placed branded semaglutide (Ozempic, Wegovy) on the drug shortage list in 2022, opening a legal window for compounders [2]. As of early 2025, the FDA has indicated it may remove semaglutide from the shortage list, which would restrict compounding. Patients considering compounded GLP-1 programs at Ro or any competitor should confirm current FDA status before committing to a multi-month plan [3].

Ro for GLP-1 Weight Loss: Best Alternatives

Ro offers compounded semaglutide injections and, more recently, compounded tirzepatide. Both target the same metabolic pathways as brand-name Wegovy and Zepbound, respectively.

The Clinical Evidence Behind GLP-1s

The STEP-1 trial (N=1,961) showed that subcutaneous semaglutide 2.4 mg once weekly produced 14.9% mean body weight reduction at 68 weeks versus 2.4% with placebo (P<0.001) [4]. The SURMOUNT-1 trial (N=2,539) showed tirzepatide 15 mg produced up to 20.9% mean weight loss at 72 weeks versus 3.1% placebo (P<0.001) [5]. These are the benchmark numbers any GLP-1 telehealth program should be measured against.

Top GLP-1 Alternatives to Ro

HealthRX. HealthRX offers physician-supervised GLP-1 programs with compounded semaglutide and tirzepatide, starting at competitive pricing with built-in lab monitoring and dose titration protocols. Unlike Ro's async intake, HealthRX uses synchronous video visits for GLP-1 onboarding.

The table below maps each competitor to its key differentiator for GLP-1 programs:

| Platform | Starting Monthly Price | Visit Type | Lab Monitoring Included | |---|---|---|---| | Ro | ~$299 | Async | No (separate cost) | | HealthRX | Competitive | Sync video | Yes | | Hims/Hers | ~$199 | Async | No | | Found | ~$99 (coaching) + Rx | Async | Partial | | Calibrate | ~$149 | Sync video | Yes |

Hims/Hers. Hims/Hers entered the GLP-1 market in 2023. Their compounded semaglutide program prices are lower than Ro's but their clinical oversight model is also async-first. Patients who need frequent dose adjustments may find async messaging inadequate.

Found. Found combines behavioral coaching with GLP-1 prescribing. Their platform is appropriate for patients who want structured lifestyle programming alongside medication. Found's 2023 outcomes data (N=7,000+ members) showed an average 9% body weight reduction at 12 weeks in patients adherent to both coaching and medication, though this is observational data without a control arm [6].

Who Should Choose Ro for GLP-1?

Patients who already have a confirmed GLP-1 prescription and want a streamlined refill pathway may find Ro's pharmacy integration convenient. Patients starting fresh, who need careful titration support, are likely better served by a platform offering synchronous visits.

Ro for Erectile Dysfunction: Best Alternatives

Ro's Roman platform (rebranded under the Ro umbrella) was one of the first D2C ED telehealth services in the United States, launching in 2017. It offers sildenafil, tadalafil, and vardenafil, including a chewable "Roman Swipes"-style product.

ED Drug Evidence

Sildenafil (Viagra) achieves erections sufficient for intercourse in approximately 70% of men with erectile dysfunction across clinical trials [7]. Tadalafil's 36-hour window, confirmed in multiple placebo-controlled studies, makes it the preferred agent for men who want spontaneity [8]. The FDA has approved both drugs, and generic versions are widely available at very low cost, which undercuts most telehealth platform markups significantly.

Pricing Reality

Generic sildenafil retails for under $1 per pill at GoodRx-affiliated pharmacies for the 20 mg dose [9]. Ro charges a prescription fee plus medication cost. For men who simply need a generic ED prescription, a primary care visit or platforms like Hims, eDrugstore, or Vault Health may offer lower total cost.

H3 Top ED Alternatives to Ro

Hims. Hims was built alongside Roman as a D2C men's health brand. Their sildenafil pricing runs approximately $2 to $4 per dose for generic, slightly below Ro's equivalent. Their app interface is marginally more polished for refills.

Vault Health. Vault Health targets men over 40 and combines testosterone assessment with ED treatment. For men whose ED has a hormonal component, Vault's lab-integrated approach is clinically more thorough than a single async ED consult.

Manual (UK-based, US expanding). Manual offers a structured ED program with ongoing clinician check-ins. Its model is closer to a longitudinal care relationship than a prescription vending service.

GoodRx Care. GoodRx Care provides telehealth visits for ED at approximately $20 per visit, the lowest-cost legitimate option for men who have no complicating factors and simply need a prescription sent to their local pharmacy.

Ro for Hair Loss: Best Alternatives

Ro's hair loss program covers finasteride (for androgenetic alopecia in men), minoxidil (topical and oral), and dutasteride (off-label). These are the same drugs offered across virtually every hair loss telehealth platform.

Hair Loss Drug Evidence

The 5-alpha reductase inhibitor finasteride 1 mg daily, studied in two key trials (N=1,553 combined), increased hair count by a mean of 107 hairs per square centimeter at 2 years compared with a 50-hair decrease in placebo groups [10]. Oral minoxidil at doses of 0.25 mg to 2.5 mg daily has shown efficacy in multiple small randomized controlled trials, with a 2022 meta-analysis (N=634 participants) showing statistically significant improvements in hair density scores (P<0.05) [11].

Top Hair Loss Alternatives to Ro

Keeps. Keeps is arguably Ro's most direct competitor for men's hair loss. Keeps offers finasteride at approximately $25 per month and minoxidil at approximately $10 per month, both lower than Ro's equivalent pricing. Keeps does not offer dutasteride, which may matter for patients who have not responded to finasteride.

Hims. Hims offers a combination finasteride/minoxidil topical product and oral minoxidil. Their pricing is comparable to Keeps. Hims also carries branded finasteride formulations with added ingredients (like biotin), though the clinical evidence for these additives is weak.

Nuo Therapeutics / Xyon Health. Xyon offers scalp-targeted finasteride in a topical liposomal delivery system (dutasteride topical as well), which may reduce systemic DHT suppression and associated sexual side effects. For patients concerned about finasteride's side-effect profile, this is a clinically meaningful alternative.

Dermatologist Visit. For moderate-to-severe androgenetic alopecia, a board-certified dermatologist visit remains the gold standard. Telehealth platforms are appropriate for mild-to-moderate presentation but cannot perform a scalp biopsy or trichoscopy.

Ro for Mental Health: Best Alternatives

Ro's mental health program (formerly Rory for women, rebranded under Ro) offers SSRIs (sertraline, escitalopram), SNRIs (venlafaxine), and anxiety medications (buspirone). The intake process is primarily asynchronous.

The Clinical Concern With Async-Only Prescribing

The American Psychiatric Association's 2023 telepsychiatry guidelines state that "synchronous audio-visual contact is preferred for initial psychiatric evaluations" and that asynchronous messaging alone is "insufficient for establishing a diagnosis of a moderate or severe mood disorder" [12]. Ro's model for mental health does not consistently meet this bar for initial evaluations.

When Ro's Mental Health Program Is Appropriate

For patients with mild anxiety or mild depression who have already been evaluated in person and need a refill pathway, Ro's async model is reasonable. For anyone starting antidepressant therapy for the first time, a synchronous video visit with a licensed prescriber is the more appropriate standard.

Top Mental Health Alternatives to Ro

Cerebral. Cerebral offers synchronous video visits with prescribers for depression and anxiety. The company faced regulatory scrutiny in 2022 over controlled substance prescribing for ADHD [13], but its non-controlled substance program (SSRIs, SNRIs) has continued operating and uses synchronous visits for initial intake.

Brightside Health. Brightside is one of the most evidence-based telehealth mental health platforms. Their 2021 published outcomes study (N=1,005) showed 71% of patients with depression achieved symptom remission within 12 weeks on their personalized medication protocol [14]. They use synchronous video for all initial prescribing evaluations.

Done / Ahead / Talkiatry. These platforms specialize in psychiatry-level care with board-certified psychiatrists rather than nurse practitioners or physician assistants, which matters for complex presentations.

SAMHSA National Helpline. For patients in crisis or without insurance, the SAMHSA National Helpline (1-800-662-4357) provides 24/7 free referrals to local mental health services [15].

How to Choose: A Decision Framework

The right telehealth platform depends on three factors: clinical complexity, budget, and how often you need to interact with your prescriber.

Low complexity, budget-conscious: For straightforward ED or mild hair loss, GoodRx Care or Keeps beat Ro on price with comparable clinical quality.

GLP-1 weight loss: Patients with a BMI <30 who do not meet FDA labeling criteria for semaglutide (BMI 30 or higher, or BMI 27 or higher with a weight-related comorbidity) should not be on a GLP-1 program at any platform, including Ro [16]. For eligible patients, choose a platform with synchronous dosing check-ins.

Mental health: Never initiate antidepressant therapy through an async-only platform. Brightside Health or a local psychiatric referral through SAMHSA is more appropriate for first-time prescribing.

Hormonal complexity (TRT, HRT, thyroid): Ro does not offer testosterone replacement therapy or comprehensive hormone panels as of early 2025. HealthRX, Maximus, Marek Health, or Plume (for transgender hormone care) are purpose-built for these needs.

Ro Reviews: What Patient Data Actually Shows

Ro holds a 3.9 out of 5 rating on Trustpilot across approximately 4,500 reviews as of early 2025, with common praise for prescription speed and pharmacy integration, and common complaints centered on customer service response times and cancellation difficulty. Independent review aggregators show a similar pattern across Hims, Hims/Hers, and Roman, suggesting these complaints reflect D2C telehealth industry norms rather than Ro-specific failures.

The FTC has noted in its 2023 report on subscription practices that auto-renewing telehealth subscriptions often obscure cancellation procedures [17]. Patients considering Ro or any subscription-based telehealth service should document cancellation steps before subscribing.